Dr. Lin Zhao 赵林
Chief Physician
Department of Breast Surgery, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Imaging diagnosis of breast tumors, comprehensive treatment of breast cancer, and breast-conserving surgery for early-stage breast cancer.
Dr. Lin Zhao is a Chief Physician with a doctorate in oncology and a master’s supervisor at China Medical University. With over 20 years of clinical experience in breast tumor diagnosis and treatment, Dr. Zhao completed advanced training at the affiliated hospital of Saga Medical University in Japan in 2004.
Name order: in Chinese the family name comes first (Zhao Lin). Papers usually list the name as Lin Zhao or Zhao L.
Selected publications
16 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Eur J Cancer, 2026 (senior author): Letter Re: COVID-19 vaccination before immune checkpoint inhibitor initiation and the overall survival of patients with advanced cancer: A cohort study. PubMed 42659835
- Phytomedicine, 2025 (senior author): Astaxanthin alleviates spinal nerve ligation-induced neuropathic pain by modulating propionic acid levels. PubMed 39951970
- Genes Dis, 2025 (senior author): Extrachromosomal circular DNA and their roles in cancer progression. PubMed 39534571
- Front Pharmacol, 2024 (senior author): S1P/S1PR1 signaling is involved in the development of nociceptive pain. PubMed 39045057
- World J Surg Oncol, 2024 (senior author): Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China. PubMed 38582875
- Biomed Pharmacother, 2024 (first author): Diosmetin alleviates neuropathic pain by regulating the Keap1/Nrf2/NF-κB signaling pathway. PubMed 38150877
- MedComm (2020), 2023 (senior author): SNORA71C promotes development and metastasis of breast cancer by regulating RUNX1 and ferroptosis. PubMed 37077773
- Oncogene, 2021 (first author): NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay. PubMed 34163032
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion